Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/02/2008CA2677646A1 Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints
10/02/2008CA2583658A1 Multi-carotenoids compositions and uses therefor
10/01/2008EP1975620A2 Three hybrid assay system
10/01/2008EP1975238A1 Gene construct, vector and dna vaccine for the vaccination of aquatic animals
10/01/2008EP1975234A2 Therapeutic and diagnotics agents capable of modulating cellular responsiveness to cytokines
10/01/2008EP1975177A1 An appetite-suppressing peptide, its compositions and use
10/01/2008EP1975168A1 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation
10/01/2008EP1975165A1 Substituted pyrrolidinamides, their production and utilisation as medicine
10/01/2008EP1975164A2 Octahydrobenzimidazolone compounds as analgetics
10/01/2008EP1975163A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
10/01/2008EP1975162A1 Oxazolone derivative
10/01/2008EP1975161A1 Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments
10/01/2008EP1975159A1 2,3,4,9-Tetrahydro-1H-carbazoles
10/01/2008EP1975158A1 Novel pyrrole derivatives with histone deacetylase inhibitor activity
10/01/2008EP1975153A2 Protease inhibitors
10/01/2008EP1974752A1 Subcellular targeting of therapeutic proteins
10/01/2008EP1974750A1 Preventive or therapeutic agent and method for immune disease
10/01/2008EP1974748A2 Antibodies for the diagnosis of diseases associated with fibrosis
10/01/2008EP1974739A1 Methods and compounds for modulating inflammatory processes
10/01/2008EP1974738A2 Diagnostics and therapeutics for glaucoma
10/01/2008EP1974732A1 Therapeutic agent for neurodegenerative disease
10/01/2008EP1974731A1 Antitussive agent
10/01/2008EP1974730A1 Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
10/01/2008EP1974729A1 Substituted imidazopyridine derivates as melanocortin- 4 receptor antagonists
10/01/2008EP1974728A1 Lipid metabolism improving composition
10/01/2008EP1974727A1 Therapeutic agent for acute cerebral infarct
10/01/2008EP1974725A1 Sustained release preparation and method for production thereof
10/01/2008EP1974724A2 Oral preparations with good disintegration
10/01/2008EP1974722A2 Modified dosage forms of tacrolimus
10/01/2008EP1974721A1 Injectable sterile pharmaceutical composition with piperacillin sodium and tazobactam sodium as active principles
10/01/2008EP1974035A1 Interfering rnas targeting the morbillivirus nucleoprotein gene
10/01/2008EP1973930A2 Cyclic peptides and their use in treating advanced stage neuroblastoma
10/01/2008EP1973924A1 Amorphous telithromycin compound
10/01/2008EP1973919A2 One pot synthesis of tetrazole derivatives of sirolimus
10/01/2008EP1973918A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/01/2008EP1973916A1 PYRROLO Ýl,2-A¨QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF
10/01/2008EP1973915A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/01/2008EP1973914A2 Transforming growth factor modulators
10/01/2008EP1973913A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives
10/01/2008EP1973911A2 Azaindoles useful as inhibitors of janus kinases
10/01/2008EP1973910A1 Pyrrolo ý3,2-c¨pyridine-4-one 2-indolinone protein kinase inhibitors
10/01/2008EP1973909A2 Transforming growth factor modulators
10/01/2008EP1973907A1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
10/01/2008EP1973906A1 Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
10/01/2008EP1973905A1 Compounds
10/01/2008EP1973904A2 Muscarinic agonists and methods of use thereof
10/01/2008EP1973903A1 Substituted 4-phenylpiperidines
10/01/2008EP1973902A2 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
10/01/2008EP1973901A1 Hydantoin derivatives for the treatment of inflammatory disorders
10/01/2008EP1973900A1 Hydantoin compounds for the treatment of inflammatory disorders
10/01/2008EP1973898A1 Pdf inhibitors
10/01/2008EP1973897A2 Substituted pyrymidine derivatives useful in the treatment of cancer and other disorders
10/01/2008EP1973894A2 Method for preparation of amorphous, anhydrous crystalline, or hydrated crystalline docetaxel
10/01/2008EP1973889A2 Cetp inhibitors
10/01/2008EP1973887A1 Aza heterocyclics for the treatment of malaria or aids
10/01/2008EP1973886A2 Prokineticin 1 receptor antagonists
10/01/2008EP1973884A2 Novel heterocycles
10/01/2008EP1973883A2 Novel compounds and methods for their production
10/01/2008EP1973882A1 Piperazine derivatives as farnesyl protein transferase inhibitors
10/01/2008EP1973880A1 Piperazinyl derivatives as modulators of chemokine receptor activity
10/01/2008EP1973876A2 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors
10/01/2008EP1973875A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
10/01/2008EP1973872A1 Inhibitors of histone deacetylase and prodrugs thereof
10/01/2008EP1973871A1 Diphenyl urea derivatives
10/01/2008EP1973868A1 Novel elatonin ligands having antidepressant activity as well as sleep inducing properties
10/01/2008EP1973610A1 Use of polyunsaturated compounds as whitening agents
10/01/2008EP1973569A2 Specific therapy using integrin ligands for treating cancer
10/01/2008EP1973555A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts
10/01/2008EP1973554A2 Cartilage repair methods
10/01/2008EP1973552A2 Parenteral nutrition composition containing iron
10/01/2008EP1973551A1 Method and composition for treating and diagnosing restless legs syndrome
10/01/2008EP1973550A2 Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
10/01/2008EP1973549A2 Methods and compositions for administration of iron
10/01/2008EP1973548A2 Soft protease inhibitors and pro-soft forms thereof
10/01/2008EP1973547A1 Compounds having cytokine modulating properties
10/01/2008EP1973545A2 Bicyclic heteroaryl compounds
10/01/2008EP1973543A2 Modulators of muscarinic receptors
10/01/2008EP1973542A2 Treatment of cachexia with statins
10/01/2008EP1973541A2 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
10/01/2008EP1973540A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
10/01/2008EP1973539A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
10/01/2008EP1973538A2 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421
10/01/2008EP1973537A1 Carbamate antibiotics
10/01/2008EP1973536A2 Treatment of fatty liver
10/01/2008EP1973535A2 Method for the treatment of tinnitus
10/01/2008EP1973532A1 Stable pharmaceutical formulation of an acid labile compound and process for preparing the same
10/01/2008EP1973528A2 Sustained-release formulations of topiramate
10/01/2008EP1973524A1 Concentrated liquid thyroid hormone composition
10/01/2008EP1973427A2 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers
10/01/2008EP1973425A1 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product
10/01/2008EP1973423A1 Formulation comprising a polyphenol-containing composition and isomaltulose
10/01/2008EP1973418A1 Novel use of a nutraceutical composition in animal feed
10/01/2008EP1973409A2 Novel phytic citrate compounds and process for preparing the same
10/01/2008EP1973407A2 Spiro compounds and methods of use
10/01/2008EP1973405A2 Hydroxyalkylarylamide derivatives
10/01/2008EP1973398A1 Use of inositol-tripyrophosphate in treating tumors and diseases
10/01/2008EP1885363B1 Use of 3,11b-cis-dihydrotetrabenazine for the treatment of symptoms of huntington' s disease
10/01/2008EP1765317B1 Materials and methods for improving shellfish health, immunity and growth
10/01/2008EP1732922B1 Methods for minimizing thioamide impurities
10/01/2008EP1713477B1 Combination of voriconazole and an antifungal cyp2c19 inhibitor